Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8714894 | Journal of the American Academy of Dermatology | 2018 | 38 Pages |
Abstract
Dual neutralization of IL-17A and IL-17F with bimekizumab provided rapid and substantial clinical improvements in patients with psoriasis, with no unexpected or dose-related safety findings.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Kim A. MD, Joseph F. MD, Alice B. MD, PhD, Christopher E.M. MD, Nancy MD, Luke MS, Christopher PhD, Andrew MD,